Human rhinovirus (HRV) infections up-regulate proinflammatory mediators and growth factors that are associated with exacerbations of inflammatory airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD). Matrix metalloproteinase (MMP)-9 was shown to be increased in the airways of patients with asthma and COPD. We sought to determine whether HRV infection modulated the expression of MMP-9 and its highest-affinity inhibitor, the tissue inhibitor of metalloproteinase (TIMP)-1, and we explored the mechanism by which this modulation occurs. In vitro studies, using RT-PCR, ELISA, zymography, and a fluorescent activity assay, demonstrated that MMP-9 mRNA, protein, and activity were increased upon infection with HRV, whereas TIMP-1 mRNA and protein remained unchanged. These results were verified in vivo, using nasal lavage samples obtained from subjects with confirmed rhinovirus infections. Human rhinovirus infections were shown to up-regulate NF-kB, and NF-kB has also been reported to play a role in the expression of MMP-9. We therefore investigated the role of NF-kB in HRV-induced MMP-9 expression. Using two inhibitors of IkBa kinase b, we observed a concentration-dependent decrease in HRVinduced MMP-9 expression. The role of NF-kB in HRV-induced MMP-9 expression was further confirmed using MMP-9 promoter luciferase constructs, which demonstrated that an NF-kB site at 2620/2607 base pairs was necessary for HRV-induced MMP-9 expression. Electrophoretic mobility shift assays and supershift assays confirmed the nuclear translocation and binding of p50/p65 NF-kB subunits to an MMP-9-specific NF-kB oligonucleotide. This increase in MMP-9 may be a mechanism by which rhinovirus infections contribute to airway inflammation and, potentially, to airway remodeling.Keywords: airway epithelial cell; airway inflammation; airway remodeling; human rhinovirus; matrix metalloproteinase-9Human rhinovirus (HRV) infections are associated with exacerbations of lower airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD) (1). More than 100 serotypes of HRV exist, and they may be grouped according to the cell surface receptor used to gain entry into airway epithelial cells, which are their primary site of infection (2, 3). More than 90% of these HRV serotypes belong to the major group that attaches to the host cell via intercellular adhesion molecule-1, whereas at least 10 serotypes belong to the minor group and use members of the low-density lipoprotein receptor family for attachment (4).Although HRV infections are strongly linked to exacerbations of asthma and COPD, the mechanisms by which such infections cause these exacerbations are not yet fully characterized. It was demonstrated that the HRV infection of airway epithelial cells in vitro induces the production of various cytokines, chemokines, growth factors, and host defense proteins, several of which are also detected in airway secretions during in vivo HRV infections (5, 6). According to the current paradigm, these cellular products s...